Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY-NC-ND 4.0Infectious Medicine

Exosomes in infectious diseases: From pathogenic exploitation to next-generation diagnostics and therapeutics

  1. 1Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, 9177948564, Iran
  2. 2Vector-borne Diseases Research Center, North Khorasan University of Medical Sciences, Bojnurd, 9414974877, Iran
  3. 3Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, 9453155166, Iran

Abstract

Exosomes (30–150 nm extracellular vesicles of endosomal origin) have redefined our understanding of intercellular communication during infection. This review provides a comprehensive, updated analysis of how exosomes function as double-edged swords in infectious diseases, mediating both host protective immunity and pathogen dissemination. We focus on recently discovered mechanisms (2020–2026) in bacterial, viral, parasitic, and fungal infections, including Mycobacterium tuberculosis, human immunodeficiency virus -1, severe acute respiratory syndrome coronavirus 2, Leishmania, Trypanosoma cruzi, and Candida albicans. We systematically compare shared versus unique host-pathogen interaction nodes across major pathogen groups, with particular emphasis on ESCRT-dependent versus endosomal sorting complex required for transport (ESCRT)-independent biogenesis pathways and their differential exploitation by pathogens. We identify a clear dichotomy: viruses predominantly co-opt ESCRT-dependent machinery, whereas intracellular bacteria and parasites show greater reliance on ESCRT-independent pathways involving tetraspanins and lipid rafts, likely reflecting their distinct intracellular vacuolar lifestyles. Furthermore, we critically evaluate host protective exosome functions, distinguishing mechanistic evidence from correlative findings, and we provide a balanced assessment of diagnostic and therapeutic translational hurdles. We further highlight the emergence of exosome-based liquid biopsies for early diagnosis and exosome-engineered platforms for vaccine and therapeutic delivery, while addressing critical limitations including isolation standardization, the distinction between association and causation in biomarker studies, and the absence of multi-center clinical validation. By integrating new insights into exosomal cargo sorting, organotropism, and pathogen-driven reprogramming, this review proposes a roadmap for translating exosome biology into clinical practice against infectious diseases.

Related

  1. Decoding metabolic diseases through bacterial extracellular vesicles: mechanisms, diagnostics, and therapeutics.
    Di Song, Wenhui Mo, Qiaoyu Deng +6
    Journal of nanobiotechnologyPeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationEurope PMCDOAJ
  2. Extracellular Vesicles in the Respiratory System: The Prominent Role of miRNAs in Pathophysiology, Diagnostics, and Therapeutics.
    Hong Ling, Hong Xiao, Zejian Zhong +6
    International journal of nanomedicinePeer-reviewedCC BY-NCFull textMolecular biology & gene regulationEurope PMCPMC
  3. AI-guided design and biomaterial integration for next-generation extracellular vesicle therapeutics: an evidence-weighted translational framework.
    Jiaqi Tian, Qiang Li, Ning Li +6
    Journal of nanobiotechnologyPeer-reviewedCC BY-NC-NDFull text1 citedMolecular biology & gene regulationEurope PMCDOAJ
  4. Lipid droplets at the interface of plant defense and pathogen exploitation
    Nathalie Arvy, Marguerite Batsale, Sara Shakir +3
    Frontiers in Plant SciencePeer-reviewedCC BY-NC 4.0Full textProteomics & metabolomicsImmunologyHAL
  5. Encapsulated mitochondrial transplantation: Advancing organelle therapeutics
    Hae-Jun Yang, Pil-Soo Jeong, Sun-Uk Kim
    Signal Transduction and Targeted TherapyPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationPMCEurope PMC
BibTeX
@article{khosrojerdi2026exosomes,
  title = {{Exosomes in infectious diseases: From pathogenic exploitation to next-generation diagnostics and therapeutics}},
  author = {Mahsa Khosrojerdi and Seyed Ahmad Hashemi and Reza Besharati and Amir Azimian},
  journal = {Infectious Medicine},
  year = {2026},
  month = oct,
  doi = {10.1016/j.imj.2026.100291},
  url = {https://doi.org/10.1016/j.imj.2026.100291},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Exosomes in infectious diseases: From pathogenic exploitation to next-generation diagnostics and therapeutics
AU  - Mahsa Khosrojerdi
AU  - Seyed Ahmad Hashemi
AU  - Reza Besharati
AU  - Amir Azimian
PY  - 2026
DA  - 2026/10/13
JO  - Infectious Medicine
DO  - 10.1016/j.imj.2026.100291
UR  - https://doi.org/10.1016/j.imj.2026.100291
AB  - Exosomes (30–150 nm extracellular vesicles of endosomal origin) have redefined our understanding of intercellular communication during infection. This review provides a comprehensive, updated analysis of how exosomes function as double-edged swords in infectious diseases, mediating both host protective immunity and pathogen dissemination. We focus on recently discovered mechanisms (2020–2026) in bacterial, viral, parasitic, and fungal infections, including Mycobacterium tuberculosis, human immunodeficiency virus -1, severe acute respiratory syndrome coronavirus 2, Leishmania, Trypanosoma cruzi, and Candida albicans. We systematically compare shared versus unique host-pathogen interaction nodes across major pathogen groups, with particular emphasis on ESCRT-dependent versus endosomal sorting complex required for transport (ESCRT)-independent biogenesis pathways and their differential exploitation by pathogens. We identify a clear dichotomy: viruses predominantly co-opt ESCRT-dependent machinery, whereas intracellular bacteria and parasites show greater reliance on ESCRT-independent pathways involving tetraspanins and lipid rafts, likely reflecting their distinct intracellular vacuolar lifestyles. Furthermore, we critically evaluate host protective exosome functions, distinguishing mechanistic evidence from correlative findings, and we provide a balanced assessment of diagnostic and therapeutic translational hurdles. We further highlight the emergence of exosome-based liquid biopsies for early diagnosis and exosome-engineered platforms for vaccine and therapeutic delivery, while addressing critical limitations including isolation standardization, the distinction between association and causation in biomarker studies, and the absence of multi-center clinical validation. By integrating new insights into exosomal cargo sorting, organotropism, and pathogen-driven reprogramming, this review proposes a roadmap for translating exosome biology into clinical practice against infectious diseases.
SN  - 2097-0684
SN  - 2772-431X
ER  -